AS 1405
Alternative Names: AngioMab; AS1405; Monoclonal antibody BC1 Y 90; R 1405; Y90 mBC1; Yttrium 90 labelled monoclonal antibody BC1Latest Information Update: 07 May 2005
At a glance
- Originator Antisoma
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glioblastoma
Most Recent Events
- 07 May 2005 Discontinued - Phase-I for Glioblastoma in United Kingdom (Parenteral)
- 03 Mar 2005 AS 1405 is available for partnering (http://www.antisoma.com)
- 04 May 2004 Phase-I clinical trials in Glioblastoma in United Kingdom (Parenteral)